Search Results

There are 7031 results for: content related to: Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing–remitting multiple sclerosis patients

  1. You have free access to this content
    Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Graziella Filippini, Cinzia Del Giovane, Laura Vacchi, Roberto D'Amico, Carlo Di Pietrantonj, Deirdre Beecher and Georgia Salanti

    Published Online : 6 JUN 2013, DOI: 10.1002/14651858.CD008933.pub2

  2. You have free access to this content
    Cost-Effectiveness of Interferon Beta-1a, Interferon Beta-1b, and Glatiramer Acetate in Newly Diagnosed Non-primary Progressive Multiple Sclerosis

    Value in Health

    Volume 7, Issue 5, September 2004, Pages: 554–568, Lisa A. Prosser, Karen M. Kuntz, Amit Bar-Or and Milton C. Weinstein

    Version of Record online : 13 SEP 2004, DOI: 10.1111/j.1524-4733.2004.75007.x

  3. Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response

    European Journal of Neurology

    Volume 19, Issue 6, June 2012, Pages: 899–904, J. Río, M. Tintoré, J. Sastre-Garriga, C. Nos, J. Castilló, C. Tur, M. Comabella and X. Montalban

    Version of Record online : 31 JAN 2012, DOI: 10.1111/j.1468-1331.2011.03648.x

  4. You have full text access to this OnlineOpen article
    Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy

    European Journal of Neurology

    Volume 21, Issue 3, March 2014, Pages: 377–e20, M. S. Freedman

    Version of Record online : 15 NOV 2013, DOI: 10.1111/ene.12299

  5. You have free access to this content
    Glatiramer acetate inhibition of tumor necrosis factor-α-induced RANTES expression and release from U-251 MG human astrocytic cells

    Journal of Neurochemistry

    Volume 77, Issue 5, June 2001, Pages: 1208–1217, Qingdi Q. Li, ,, David R. Burt and Christopher T. Bever,,

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1471-4159.2001.00327.x

  6. You have free access to this content
    An overview of pregnancy-related issues in patients with multiple sclerosis

    European Journal of Neurology

    Volume 22, Issue S2, October 2015, Pages: 34–39, C. Pozzilli and M. Pugliatti

    Version of Record online : 16 SEP 2015, DOI: 10.1111/ene.12797

  7. Current Disease-Modifying Treatment of Multiple Sclerosis

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 78, Issue 2, March/April 2011, Pages: 161–175, Joy Derwenskus

    Version of Record online : 21 MAR 2011, DOI: 10.1002/msj.20239

  8. You have free access to this content
    Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Irene Tramacere, Cinzia Del Giovane, Georgia Salanti, Roberto D'Amico and Graziella Filippini

    Published Online : 18 SEP 2015, DOI: 10.1002/14651858.CD011381.pub2

  9. You have full text access to this OnlineOpen article
    Disease-modifying treatments for multiple sclerosis – a review of approved medications

    European Journal of Neurology

    Volume 23, Issue S1, January 2016, Pages: 18–27, Ø. Torkildsen, K.-M. Myhr and L. Bø

    Version of Record online : 13 NOV 2015, DOI: 10.1111/ene.12883

  10. Glatiramer acetate for multiple sclerosis

    Intervention Review

    The Cochrane Library

    Loredana La Mantia, Luca M Munari and Roberta Lovati

    Published Online : 12 MAY 2010, DOI: 10.1002/14651858.CD004678.pub2

  11. A prospective, open-label treatment trial to compare the effect of IFN β-1a (Avonex), IFNβ-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis

    European Journal of Neurology

    Volume 8, Issue 2, March 2001, Pages: 141–148, O. A. Khan, A. C. Tselis, J. A. Kamholz, J. Y. Garbern, R. A. Lewis and R. P. Lisak

    Version of Record online : 7 JUL 2008, DOI: 10.1046/j.1468-1331.2001.00189.x

  12. Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. A report of two cases

    Journal of Cutaneous Pathology

    Volume 35, Issue 4, April 2008, Pages: 407–410, Nigel J. Ball, Bryce J. Cowan, G. R. Wayne Moore and Stanley A. Hashimoto

    Version of Record online : 1 OCT 2007, DOI: 10.1111/j.1600-0560.2007.00819.x

  13. Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-α) does not improve experimental autoimmune encephalomyelitis

    Annals of Neurology

    Volume 47, Issue 1, January 2000, Pages: 127–131, Staley A. Brod, J. William Lindsey and Jerry S. Wolinsky

    Version of Record online : 19 APR 2001, DOI: 10.1002/1531-8249(200001)47:1<127::AID-ANA22>3.0.CO;2-1

  14. IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient

    Pediatric Allergy and Immunology

    Volume 25, Issue 8, December 2014, Pages: 821–823, E. Crestani, J. Lee, M. Gorman, M. Castells and A. F. Dioun Broyles

    Version of Record online : 16 OCT 2014, DOI: 10.1111/pai.12267

  15. Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab

    European Journal of Neurology

    Volume 20, Issue 1, January 2013, Pages: 87–94, S. Rossi, C. Motta, V. Studer, V. De Chiara, F. Barbieri, F. Monteleone, A. Fornasiero, G. Coarelli, G. Bernardi, G. Cutter, O. Stüve, M. Salvetti and D. Centonze

    Version of Record online : 28 JUN 2012, DOI: 10.1111/j.1468-1331.2012.03794.x

  16. Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study

    European Journal of Neurology

    Volume 23, Issue 5, May 2016, Pages: 861–870, P. S. Sørensen, F. Sellebjerg, J. Lycke, M. Färkkilä, A. Créange, C. G. Lund, M. Schluep, J. L. Frederiksen, E. Stenager, C. Pfleger, E. Garde, E. Kinnunen, K. Marhardt and on behalf of the RECYCLINE Study Investigators

    Version of Record online : 5 FEB 2016, DOI: 10.1111/ene.12953

  17. Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis

    Intervention Review

    The Cochrane Library

    Loredana La Mantia, Carlo Di Pietrantonj, Marco Rovaris, Giulio Rigon, Serena Frau, Francesco Berardo, Anna Gandini, Anna Longobardi, Bianca Weinstock-Guttman and Alberto Vaona

    Published Online : 24 NOV 2016, DOI: 10.1002/14651858.CD009333.pub3

  18. You have free access to this content
    Overview of the management of relapsing−remitting multiple sclerosis and practical recommendations

    European Journal of Neurology

    Volume 22, Issue S2, October 2015, Pages: 14–21, P. Gallo and B. Van Wijmeersch

    Version of Record online : 16 SEP 2015, DOI: 10.1111/ene.12799

  19. Clinical and magnetic resonance imaging findings in chronic sensory ganglionopathies

    Annals of Neurology

    Volume 47, Issue 1, January 2000, Pages: 104–109, Giuseppe Lauria, Davide Pareyson, Marina Grisoli and Angelo Sghirlanzoni

    Version of Record online : 19 APR 2001, DOI: 10.1002/1531-8249(200001)47:1<104::AID-ANA17>3.0.CO;2-X

  20. Immunomodulation by the copolymer glatiramer acetate

    Journal of Molecular Recognition

    Volume 16, Issue 6, November/December 2003, Pages: 412–421, Ruth Arnon and Michael Sela

    Version of Record online : 21 NOV 2003, DOI: 10.1002/jmr.628